Literature DB >> 15983921

HIV treatment decisions and transmitted drug resistance.

Susan J Little, Davey M Smith.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15983921     DOI： 10.1086/431215

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.

Authors:  Bum Sik Chin; Hyoung-Shik Shin; Gayeon Kim; Gabriel A Wagner; Sara Gianella; Davey M Smith
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-28       Impact factor: 2.205

2.  Prevalence of transmitted drug resistance and impact of transmitted resistance on treatment success in the German HIV-1 Seroconverter Cohort.

Authors:  Barbara Bartmeyer; Claudia Kuecherer; Claudia Houareau; Johanna Werning; Kathrin Keeren; Sybille Somogyi; Christian Kollan; Heiko Jessen; Stephan Dupke; Osamah Hamouda
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

3.  Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV.

Authors:  Lilian A Inocencio; Anderson A Pereira; Maria Cecilia A Sucupira; José Carlos C Fernandez; Célia P Jorge; Denise Fc Souza; Helena T Fink; Ricardo S Diaz; Irina M Becker; Theodoro A Suffert; Monica B Arruda; Olinda Macedo; Mariangela Bg Simão; Amilcar Tanuri
Journal:  J Int AIDS Soc       Date:  2009-09-18       Impact factor: 5.396

4.  "One pill, once daily": what clinicians need to know about Atriplatrade mark.

Authors:  Patrick G Clay; Tracey Ah Taylor; Alan G Glaros; Marypeace McRae; Charlott Williams; Don McCandless; Maurice Oelklaus
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.